NCT04639609View on ClinicalTrials.gov

Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

September 6, 2021

Study Completion Date

September 6, 2021

Conditions
Breast Cancer
Interventions
OTHER

Characterization of Neuromuscular Function and Fatigue

at inclusion

Trial Locations (1)

67033

Institut de Cancerologie Strasbourg Europe, Strasbourg

All Listed Sponsors
collaborator

UR 3072 - Mitochondrie, Stress oxydant et Protection musculaire

UNKNOWN

lead

Institut de cancérologie Strasbourg Europe

OTHER

NCT04639609 - Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04) | Biotech Hunter | Biotech Hunter